Study identifier:NIS-RRO-SYM-2008/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
SMART way of treating asthma. Non-interventional study to evaluate clinical efficacy of Symbicort® Maintenance And Reliever Therapy (Symbicort® SMART) in the treatment of patients with moderate and severe asthma
Moderate/severe asthma
-
No
-
All
1182
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
The primary objective of this non-interventional study is to evaluate efficacy of Symbicort® SMART treatment in adult patients with moderate to severe asthma using ACQ scores during 6 months period
Location
Location
Alba Iulia, Romania
Location
Alexandria, Romania
Location
Arad, Romania
Location
Bacau, Romania
Location
Baia Mare, Romania
Location
Botosani, Romania
Location
Braila, Romania
Location
Brasov, Romania
Arms | Assigned Interventions |
---|---|
1 Moderate and severe asthma patients stabilized on Symbicort SMART | - |
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.